presagebio.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Presage
Description Pioneering the Future of Translational Oncology About Us About Presage Team and Board Publications News Clinical Collaboration CIVO Platform Contact Us Re
Keywords N/A
Server Information
WebSite presagebio faviconpresagebio.com
Host IP 52.24.10.57
Location United States
Related Websites
Site Rank
More to Explore
presagebio.com Valuation
US$3,321,655
Last updated: 2022-07-12 12:41:02

presagebio.com has Semrush global rank of 3,186,455. presagebio.com has an estimated worth of US$ 3,321,655, based on its estimated Ads revenue. presagebio.com receives approximately 383,268 unique visitors each day. Its web server is located in United States, with IP address 52.24.10.57. According to SiteAdvisor, presagebio.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$3,321,655
Daily Ads Revenue US$3,067
Monthly Ads Revenue US$91,985
Yearly Ads Revenue US$1,103,812
Daily Unique Visitors 25,552
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
presagebio.com. A 599 IP: 52.24.10.57
presagebio.com. NS 3600 NS Record: ns46.domaincontrol.com.
presagebio.com. NS 3600 NS Record: ns45.domaincontrol.com.
presagebio.com. MX 1800 MX Record: 10 presagebio-com.mail.protection.outlook.com.
presagebio.com. TXT 1800 TXT Record: v=spf1 include:spf.protection.outlook.com -all
presagebio.com. TXT 1800 TXT Record: WsDs3/LxR065zvonof2qRxGd9UbDM6DbcV7JeYyJrEp2jwvurvZ2i/U3yd3vmO9bnpP4O34CZwx6nT6uD9rHtA==
HtmlToTextCheckTime:2022-07-12 12:41:02
Pioneering the Future of Translational Oncology About Us About Presage Team and Board Publications News Clinical Collaboration CIVO Platform Contact Us Revolutionizing oncology drug development Presage is at the forefront of changing how novel cancer therapies are developed and promising drug combinations are identified. With Phase 0 microdose trials, evaluation of tumor-based drug activity is now possible earlier than ever before. Discover the benefit of phase 0 microdosing A bridge between early preclinical experimentation and clinical investigation Using Presage’s patented CIVO ® ( C omparative I n V ivo O ncology) platform, tumor microenvironment response to multiple investigational treatments, alone or in combination, can be observed where it matters most—in a patient’s tumor. See how CIVO works Presage Biosciences is an oncology company that is pioneering an entirely novel approach to evaluating drug responses in clinical trials. About Presage Presage’s patented CIVO ® ( C
HTTP Headers
HTTP/1.1 302 Found
Date: Sun, 31 Oct 2021 19:24:10 GMT
Server: Apache/2.4.29 (Ubuntu)
Location: https://presagebio.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/1.1 200 OK
Date: Sun, 31 Oct 2021 19:24:10 GMT
Server: Apache/2.4.29 (Ubuntu)
Last-Modified: Fri, 19 Mar 2021 21:56:27 GMT
ETag: "2288-5bdeac9ab58c0"
Accept-Ranges: bytes
Content-Length: 8840
Vary: Accept-Encoding
Content-Type: text/html
presagebio.com Whois Information
Domain Name: PRESAGEBIO.COM
Registry Domain ID: 1526991153_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-11-05T12:17:29Z
Creation Date: 2008-11-04T13:08:14Z
Registry Expiry Date: 2022-11-04T13:08:14Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS45.DOMAINCONTROL.COM
Name Server: NS46.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-19T05:11:55Z <<<